CAMBRIDGE, Mass. — Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the...

Enveric Biosciences, a Naples─headquartered biotechnology company dedicated to the development of novel neuroplastogenic small─molecule...

Stellar V Capital Corp., a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, announced the closing of...

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment...

Clifford Chance advised Keymed Biosciences on the deal. Timberlyne Therapeutics, Inc. announced its US$180 million Series A financing to advance the...

An international team of scientists has found that poor organ health in the body can contribute to poor mental health. The study was published in the...

Insider Brief PRESS RELEASE — D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software,...

TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV)...

Psychiatric disorders often overlap, with shared symptoms making diagnosis challenging. Conditions like depression and anxiety, schizophrenia and...

Cyprus is rapidly running out of the antipsychotic drug Seroquel with the higher dosages especially being in short supply since early October, the...